The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular The peptide problem: Hype is outrunning the evidence FDA Moves to Reevaluate Several Peptides American Med Spa Association The FDA's Current Position on Peptides Explained Holt Law Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Medicine Springer Nature Link